← Back to Search

Bupivacaine Injection for Drug Effects

Phase < 1
Waitlist Available
Led By Prashant Upadhyaya, MD
Research Sponsored by State University of New York - Upstate Medical University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be receiving bilateral breast reduction surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial is testing whether injecting Marcaine into one breast during surgery can reduce post-operative pain more than injecting saline into the other breast.

Eligible Conditions
  • Drug Effects

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Marcaine Use in Breast Reconstruction: Post-Operative Pain Scale Assessment per Breast

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment Group (Marcaine 1 Breast)Experimental Treatment1 Intervention
Marcaine will be injected into one randomized breast and saline into the other in the treatment group.
Group II: Control Group (Marcaine 2 Breasts)Active Control1 Intervention
Marcaine will be injected into both breasts as is currently the standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine Injection
2017
Completed Phase 4
~580

Find a Location

Who is running the clinical trial?

State University of New York - Upstate Medical UniversityLead Sponsor
172 Previous Clinical Trials
27,310 Total Patients Enrolled
Prashant Upadhyaya, MDPrincipal InvestigatorSUNY Upstate Medical University - Syracuse, NY

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum number of volunteers allowed to participate in this experiment?

"Unfortunately, this clinical trial has stopped recruiting patients. It was initially listed on December 9th 2020 and its last update happened on May 9th 2022. Nonetheless, there are still many trials searching for participants in the fields of postoperative pain management (517) and Bupivacaine Injection (110)."

Answered by AI

What precedent exists for utilizing Bupivacaine Injection in medical research?

"Currently, there are 110 active clinical trials involving Bupivacaine Injection. With 18 of these at Phase 3, it is clear that this treatment has advanced in the medical field. Research for this injection is primarily based out of Philadelphia, Pennsylvania but is being conducted across 147 sites across the nation."

Answered by AI

What medical conditions typically necessitate the use of Bupivacaine Injection?

"Bupivacaine Injection is a suitable treatment for pemphigus, as well as acute nonspecific tenosynovitis, general anesthesia and lupus erythematosus cell."

Answered by AI

Is this research project currently looking for participants?

"At the moment, this specific study is no longer recruiting patients. It was first made available on December 9th 2020 and had its last update on May 9th 2022. However, individuals searching for other medical trials can find 517 studies related to pain postoperative and 110 clinical trials involving bupivacaine injection actively looking for participants."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~5 spots leftby Apr 2025